Procedure for relapsed/refractory sickness should be made the decision according to prior therapy and also The main reason why the first therapy was no longer appropriate (e.g., refractoriness vs. intolerance). Ibrutinib is The present gold conventional therapy for individuals with relapsed/refractory disease, based upon the outcomes of several sta